María del Mar Ayala Gutiérrez

IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus

Ming Zhao, Yin Zhou, Bochen Zhu et al. · Annals of the Rheumatic Diseases · 2016 · 223 citations · Full text

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis

Farah Tamirou, David D’Cruz, Shirish Sangle et al. · Annals of the Rheumatic Diseases · 2015 · 203 citations · Full text

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label

Cándido Díaz‐Lagares, R. Pérez-Álvarez, Francisco José García Hernández et al. · Arthritis Research & Therapy · 2011 · 70 citations · Full text

Association Between −174 <i>Interleukin-6</i> Gene Polymorphism and Biological Response to Rituximab in Several Systemic Autoimmune Diseases

Gema Robledo, Cristina Lucía Dávila-Fajardo, Ana Márquez et al. · DNA and Cell Biology · 2012 · 20 citations

Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry

María del Mar Ayala Gutiérrez, Manuel Rubio‐Rivas, Carlos Romero Gómez et al. · Journal of Clinical Medicine · 2021 · 18 citations · Full text

Barthel Index Score, Covid-19 Epidemiology, Logistic Analysis +23